Dan Rizzo, global head of Veeva Business Consulting, spoke with Pharmaceutical Executive about the state of product launches ...
It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their U.S.
Standardising analytical data is the key to unlocking AI-driven innovation in chemical and pharmaceutical research. Richard Lee, Director, Core Technology and Capabilities at ACD/Labs explores how ...
His research explores the rise of generative AI and accelerated use of AI more broadly to advance drug and scientific discovery. Reuben leads Gartner's coverage of genomics, multiomics, cell and gene ...
China, one of the countries affected by the new tariffs, is the world’s largest producer of active pharmaceutical ingredients ...
Gulf Energy Information and DECHEMA—organizers of the world’s leading trade show for the Process Industries ACHEMA—are thrilled to announce a groundbreaking partnership to launch the new annual ...
Experts at the 2025 Clinical Trial Supply Europe conference will explore supply chain challenges and the impact of AI on ...
The last few days have been a rollercoaster for the pharmaceutical industry. Mexico and Canada were bracing themselves for ...
Vietnam’s pharmaceutical market is expected to have a year of optimism after experiencing a multicoloured gamut in 2024.
AI’s role in healthcare evolved significantly in 2024. Rather than generic AI solutions, startups focused on specialized, ...
Entering 2025, the CDMO industry is at a crossroads. Reflecting on conversations over the past year—with CEOs navigating ...
Major employers and innovators recognised at ceremony showcasing Ireland’s pharmaceutical leadership, as sector marks record ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results